Clinical Trial Update: An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase I/II study evaluating a pan-immunotherapy in local advanced/metastatic pancreatic cancer is ongoing; no results or status are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN